Healthcare advancements promise new treatments for weight loss and cancer in 2025

In 2024, significant advancements in healthcare emerged, particularly in weight-loss treatments and cancer therapies. New GLP-1 drugs like Wegovy and Zepbound are gaining traction, with FDA approvals for weight management and cardiovascular risk reduction. Cheaper generics are expected after key patents expire in 2026. Immunotherapy is transforming cancer treatment, with India launching its first CAR-T cell therapy, NexCAR19. This affordable therapy targets specific blood cancers. In the UK, personalized cancer vaccines using mRNA technology are being developed, expanding treatment options for various cancers. Progress in Alzheimer’s treatment includes FDA approvals for new drugs that help clear amyloid plaques, though access remains a challenge in India. Additionally, gene-editing therapies for conditions like sickle cell disease and high cholesterol are showing promise, potentially changing treatment landscapes.